Founders Financial Alliance, LLC Guardant Health, Inc. Transaction History

Founders Financial Alliance, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$98.77 - $132.17 $173,538 - $232,222	-1,757 Closed	0 $0
Q2 2021 Aug 02, 2021	BUY	$109.77 - $165.68 $27,332 - $41,254	249 Added 16.51%	1,757 $218,000
Q1 2021 May 14, 2021	SELL	$127.04 - $179.1 $26,678 - $37,611	-210 Reduced 12.22%	1,508 $230,000
Q4 2020 Feb 04, 2021	BUY	$99.96 - $135.93 $164,334 - $223,468	1,644 Added 2221.62%	1,718 $222,000
Q3 2020 Nov 13, 2020	BUY	$80.32 - $111.8 $5,943 - $8,273	74 New	74 $7,000

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.59B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Founders Financial Alliance, LLC, based on Form 13F filings with the SEC.

Stay updated on Founders Financial Alliance, LLC with notifications on news.